Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unveiling the anti-cancer potentiality of phthalimide-based Analogues targeting tubulin polymerization in MCF-7 cancerous Cells: Rational design, chemical Synthesis, and Biological-coupled Computational investigation.
Aljuhani A, Nafie MS, Albujuq NR, Hourani W, Albelwi FF, Darwish KM, Samir Ayed A, Reda Aouad M, Rezki N. Aljuhani A, et al. Among authors: hourani w. Bioorg Chem. 2024 Dec;153:107827. doi: 10.1016/j.bioorg.2024.107827. Epub 2024 Sep 18. Bioorg Chem. 2024. PMID: 39321715
Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.
Venugopala KN, Chandrashekharappa S, Deb PK, Tratrat C, Pillay M, Chopra D, Al-Shar'i NA, Hourani W, Dahabiyeh LA, Borah P, Nagdeve RD, Nayak SK, Padmashali B, Morsy MA, Aldhubiab BE, Attimarad M, Nair AB, Sreeharsha N, Haroun M, Shashikanth S, Mohanlall V, Mailavaram R. Venugopala KN, et al. Among authors: hourani w. J Enzyme Inhib Med Chem. 2021 Dec;36(1):1472-1487. doi: 10.1080/14756366.2021.1919889. J Enzyme Inhib Med Chem. 2021. PMID: 34210233 Free PMC article.
Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives.
Venugopala KN, Al-Shar'i NA, Dahabiyeh LA, Hourani W, Deb PK, Pillay M, Abu-Irmaileh B, Bustanji Y, Chandrashekharappa S, Tratrat C, Attimarad M, Nair AB, Sreeharsha N, Shinu P, Haroun M, Kandeel M, Balgoname AA, Venugopala R, Morsy MA. Venugopala KN, et al. Among authors: hourani w. Antibiotics (Basel). 2022 Jun 21;11(7):831. doi: 10.3390/antibiotics11070831. Antibiotics (Basel). 2022. PMID: 35884084 Free PMC article.
Mass spectrometry-based metabolomics approach and in vitro assays revealed promising role of 2,3-dihydroquinazolin-4(1H)-one derivatives against colorectal cancer cell lines.
Dahabiyeh LA, Hudaib F, Hourani W, Darwish W, Abu-Irmaileh B, Deb PK, Venugopala KN, Mohanlall V, Chandrashekharappa S, Abu-Dahab R, Semreen MH, Bustanji Y. Dahabiyeh LA, et al. Among authors: hourani w. Eur J Pharm Sci. 2023 Mar 1;182:106378. doi: 10.1016/j.ejps.2023.106378. Epub 2023 Jan 11. Eur J Pharm Sci. 2023. PMID: 36638899 Free article.
Current advances in the clinical development of anti-tubercular agents.
Tetali SR, Kunapaeddi E, Mailavaram RP, Singh V, Borah P, Deb PK, Venugopala KN, Hourani W, Tekade RK. Tetali SR, et al. Among authors: hourani w. Tuberculosis (Edinb). 2020 Dec;125:101989. doi: 10.1016/j.tube.2020.101989. Epub 2020 Sep 5. Tuberculosis (Edinb). 2020. PMID: 32957054 Review.
24 results